Fléchon A - Search Results

1

[Metastatic renal cell carcinoma: Management of toxicities of combinations].

Joly F, Michot JM, Dourthe LM, Fléchon A, Mahammedi H, Maillet D, Mouillet G, Pouessel D, Rolland F, Topart D, Albiges L. Joly F, et al. Among authors: flechon a. Bull Cancer. 2022 Jul-Aug;109(7-8):844-861. doi: 10.1016/j.bulcan.2022.04.019. Epub 2022 Jun 21. Bull Cancer. 2022. PMID: 35738914 Review. French.

2

[High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].

Fléchon A, Biron P, Philip I, Blay JY, Droz JP. Fléchon A, et al. Bull Cancer. 1999 Apr;86(4):391-9. Bull Cancer. 1999. PMID: 10341344 Free article. French.

3

[Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?].

Fléchon A, Droz JP. Fléchon A, et al. Bull Cancer. 2001 Sep;88(9):852-7. Bull Cancer. 2001. PMID: 11604357 Free article. Review. French.

4

[Study of the hormone-refractory prostate cancer clinical practice in an anti-cancer center].

Zufferey L, Roques B, Fléchon A, Droz JP. Zufferey L, et al. Among authors: flechon a. Bull Cancer. 2001 Dec;88(12):1213-21. Bull Cancer. 2001. PMID: 11792613 Free article. French.

5

[Management of advanced seminoma: retrospective study of 96 patients].

Bompas E, Fléchon A, Biron P, Droz JP. Bompas E, et al. Among authors: flechon a. Bull Cancer. 2002 Oct;89(10):877-85. Bull Cancer. 2002. PMID: 12441279 Free article. French.

6

[Metastatic prostate cancer].

Droz JP, Flechon A, Terret C. Droz JP, et al. Among authors: flechon a. Rev Prat. 2003 Dec 31;53(20):2258-62. Rev Prat. 2003. PMID: 15018080 French.

7

[Gemcitabine and pemetrexed in genito-urinary tumors treatment].

Fléchon A. Fléchon A. Bull Cancer. 2007;94 Spec No Actualites:S116-21. Bull Cancer. 2007. PMID: 17845980 Review. French.

8

Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer.

Italiano A, Ortholan C, Oudard S, Pouessel D, Gravis G, Beuzeboc P, Bompas E, Fléchon A, Joly F, Ferrero JM, Fizazi K. Italiano A, et al. Among authors: flechon a. Eur Urol. 2009 Jun;55(6):1368-75. doi: 10.1016/j.eururo.2008.07.078. Epub 2008 Aug 8. Eur Urol. 2009. PMID: 18706755

9

Do patients with advanced urothelial carcinoma benefit from weekly paclitaxel chemotherapy? A GETUG phase II study.

Joly F, Houédé N, Noal S, Chevreau C, Priou F, Chinet-Charrot P, Rolland F, Fléchon A, Henry-Amar M, Culine S. Joly F, et al. Among authors: flechon a. Clin Genitourin Cancer. 2009 Aug;7(2):E28-33. doi: 10.3816/CGC.2009.n.018. Clin Genitourin Cancer. 2009. PMID: 19692319 Clinical Trial.

10

[Management of side effects associated with antiangiogenic treatment in renal cell carcinoma].

Fléchon A, Boyle H, Négrier S. Fléchon A, et al. Bull Cancer. 2010;97:73-82. doi: 10.1684/bdc.2010.1072. Bull Cancer. 2010. PMID: 20418206 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters